Venture Capital Archives - Boston Life Sciences Times

How Industry Trends are Impacting Hiring Decisions and Leadership Strategies in Life Sciences

January 6, 2026

Foray Bioscience Secures First Fabricated Seed Partnership With West Coast Chestnut

January 5, 2026

instED Names Don Stiffler Chief Executive Officer

December 29, 2025

THIS WEEK'S STORIES

Orum Therapeutics Names Chad May as Chief Scientific Officer to Lead Scientific Strategy and DAC Development

January 5, 2026

Elemental Machines Launches Agentic AI Platform to Drive Autonomous Decision-Making in Life Sciences Operations

January 8, 2026

Insulet Debuts “Liveable Technology” Vision at CES 2026

January 6, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Venture Capital

Carna Health Raises $8 Million to Expand Global Chronic Kidney Disease Screening Programs

Parabilis Medicines Raises $305 Million to Advance Zolucatetide and Helicon Platform

Vizgen Raises $48 Million to Accelerate Spatial Multi-Omics Growth

Corsera Health Raises $80 Million Series A and Begins First Clinical Trial

Nocion Therapeutics Expands Series B to $93 Million to Advance Late-Stage Development of Taplucainium for Chronic Cough

Most Read

ZOLL Launches Next-Generation LifeVest Wearable Defibrillator in U.S.

Allotex Receives FDA Clearance to Begin U.S. Clinical Study for Presbyopia Device

VectorY Therapeutics’ VTx-002 Granted FDA Fast Track Designation for ALS